CMPSNasdaqPharmaceutical PreparationsFiscal year ends December 31

COMPASS Pathways plc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$11.11+0.36 (+3.35%)

Close on Oct 19, 2026

Market cap: $1.50B
P/E (TTM): –
Dividend yield: –

COMPASS Pathways plc balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Cash & Equivalents	150	165	221	143	273	190	25	23
Cash & Short-Term Investments	150	165	221	143	273	190	25	23
Prepaid Expenses & Other	42	36	41	48	22	12	7.19	–
Other Current Assets	5.58	3.58	1.90	1.04	1.37	0.51	0.74	–
Total Current Assets	191	201	261	192	295	202	32	–
Property, Plant & Equipment	–	0.19	0.42	0.62	0.40	0.25	0.22	–
Gross Property, Plant & Equipment	–	–	–	1.15	0.76	0.43	0.29	–
Accumulated Depreciation	–	–	–	-0.53	-0.36	-0.19	-0.07	–
Operating Lease Right-of-Use Assets	3.42	2.01	4.31	2.01	3.70	1.00	–	–
Deferred Tax Assets	3.75	3.77	3.34	2.22	0.77	0.22	0	–
Other Long-Term Assets	12	6.60	7.05	1.41	0.21	0.06	0	–
Total Assets	210	214	276	197	301	203	32	–
Accounts Payable	15	12	5.89	4.76	2.56	2.75	1.26	–
Current Portion of Long-Term Debt	18	5.51	0	–	–	–	–	–
Current Debt	18	5.51	0	–	–	–	–	–
Current Portion of Leases	2.11	1.73	2.41	1.51	2.24	1.00	–	–
Current Income Taxes Payable	–	0	0	0	0	0.24	0.02	–
Other Current Liabilities	0.56	1.33	1.04	0.66	0.27	0.41	0.04	–
Total Current Liabilities	248	34	20	16	15	6.90	24	–
Long-Term Debt	14	25	29	–	–	–	–	–
Long-Term Leases	1.29	0.30	1.88	0.42	1.38	–	–	–
Operating Lease Liabilities	3.40	2.03	4.29	1.93	3.61	1.00	–	–
Total Liabilities	263	59	50	16	16	6.90	24	–
Total Debt	32	30	29	–	–	–	–	–
Common Stock	0.97	0.70	0.64	–	–	–	–	–
Additional Paid-In Capital	784	705	622	459	445	279	7.16	–
Retained Earnings	-823	-535	-380	-261	-170	-98	-38	–
Comprehensive Income & Other	-15	-16	-17	-17	8.84	15	-0.10	–
Shareholders' Equity	-53	155	226	181	284	197	-30	-14
Total Equity	-53	155	226	181	284	197	-30	-14
Total Liabilities & Equity	210	214	276	197	301	203	32	–
Shares Outstanding(shares)	96	69	62	–	–	36	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -565.3%

Financial strength

Current ratio: 1.30
Debt to equity: 0.60
Debt to assets: 10.1%
Cash to current liabilities: 118.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 17.75
Dividend yield: –